Therapeutic combinations of acatinib and caspasertinib for the treatment of B-cell… Application CN-114728003-A China 08 Jul 2022
THERAPEUTIC COMBINATIONS OF ACALABRUTINIB AND CAPIVASERTIB TO TREAT B-CELL MALIGNANCIES Application WO-2021089419-A1 World Intellectual Property Organisation (WIPO) 14 May 2021
COMBINATIONS FOR TREATING CANCER Application WO-2019211721-A1 World Intellectual Property Organisation (WIPO) 07 Nov 2019